Surgical Innovations Group plc provided earnings guidance for the full year ending December 31, 2014. For the period, the board expects that the company will report a significant loss before tax. Against this backdrop, short-term working capital funding and cash generation remains the board's key priority and further updates will be provided to shareholders as appropriate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 GBX | 0.00% | 0.00% | -16.67% |
Apr. 18 | Stocks recover some of recent Fed talk losses | AN |
Apr. 18 | Surgical Innovations Group Bags UK Distribution Contracts | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.67% | 5.94M | |
-5.31% | 182B | |
-1.21% | 114B | |
-5.53% | 67.76B | |
+1.22% | 51.91B | |
+7.03% | 43.23B | |
+5.59% | 41.07B | |
+21.96% | 32.07B | |
+13.91% | 25B | |
-4.81% | 24.55B |
- Stock Market
- Equities
- SUN Stock
- News Surgical Innovations Group plc
- Surgical Innovations Group plc Provides Earnings Guidance for the Full Year Ending December 31, 2014